6,184 results on '"LUPUS NEPHRITIS"'
Search Results
2. A Study of IMPT-514 in Active Refractory Lupus Nephritis (LN) and Systemic Lupus Erythematosus (SLE)
3. A Study to Evaluate the Efficacy and Safety of Tacrolimus With Steroid in Korean Lupus Nephritis Patients (APPLE)
4. A Study to Assess Effectiveness and Safety of Efgartigimod in Chinese Patients with Lupus Nephritis (ZL-1103-013)
5. A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of Obinutuzumab in Adolescents With Active Class III or IV Lupus Nephritis and the Safety and PK of Obinutuzumab in Pediatric Participants (POSTERITY)
6. Study to Assess Demographic, Pharmacologic, Biomarker, Clinical Features and Quality of Life (QoL) of Participants With Lupus Nephritis
7. Urinary Congophilia As an Indicator of Activity of Lupus Nephritis (lupus nephriti)
8. Evaluation of Patients With Lupus Nephritis Using Kidney MRI (Magnetic Resonance Imaging)
9. A Study to Evaluate the Safety and Efficacy of Tacrolimus for Lupus Nephritis Under Actual Use Situations (TRUST)
10. The Pediatric Lupus Nephritis Mycophenolate Mofetil (PLUMM) Study (PLUMM)
11. Phase 3 Study of Anifrolumab in Adult Patients With Active Proliferative Lupus Nephritis (IRIS)
12. A Study To Evaluate The Efficacy And Safety Of Obinutuzumab In Patients With ISN/RPS 2003 Class III Or IV Lupus Nephritis (REGENCY)
13. Monitoring Lupus Nephritis Through Urinary Extracellular Vesicles
14. Fourth-gen CAR T Cells Targeting BCMA/CD19 for Refractory Systemic Lupus Erythematosus (SLE) (BAH242)
15. A Study of CNTY-101 in Participants With Refractory B Cell-mediated Autoimmune Diseases (CALiPSO-1) (CALiPSO-1)
16. Study to Assess Real-world Effectiveness of Belimumab for Treatment of Adults With LN (OBSErve-LN)
17. SGLT2 Inhibitors Between Reno Protective Effects and Impact on Bone and Mineral Disease Among Lupus Nephritis Patients
18. Study of Safety, Efficacy and Tolerability of Secukinumab Versus Placebo, in Combination With SoC Therapy, in Patients With Active Lupus Nephritis (SELUNE)
19. A Study of Zetomipzomib (KZR-616) in Patients With Active Lupus Nephritis (PALIZADE)
20. A Study of Nipocalimab in Adult Participants With Active Lupus Nephritis
21. NKX019, Intravenous Allogeneic Chimeric Antigen Receptor Natural Killer Cells (CAR NK), in Adults With Autoimmune Disease (Ntrust-1)
22. Renal Arterial Resistive Index as a Noninvasive Biomarker of Disease Activity in Lupus Nephritis Patients
23. Safety, Pharmacokinetics and Preliminary Efficacy Study of CFZ533 in Patients With Lupus Nephritis.
24. Safety, Efficacy and Tolerability of Ianalumab Versus Placebo, Combination With SoC Therapy, in Participants With Active Lupus Nephritis (SIRIUS-LN)
25. A Study of Rapcabtagene Autoleucel in Systemic Lupus Erythematosus (SLE) Patients With Active, Refractory Lupus Nephritis (LN)
26. Study of ALXN2050 in Proliferative Lupus Nephritis (LN) or Immunoglobulin A Nephropathy (IgAN)
27. Study of Ravulizumab in Proliferative Lupus Nephritis (LN) or Immunoglobulin A Nephropathy (IgAN) (SANCTUARY)
28. Autologous CD19 CAR-T Cell Therapy (SYNCAR-001) + Orthogonal IL-2 (STK-009) in Subjects With Severe, Refractory Systemic Lupus Erythematosus
29. Association Between Neuropathy and Some Autoantibodies in Systemic Lupus Erythematosus (SLE) Patients
30. A Study of Felzartamab in Participants With Lupus Nephritis
31. A Study of Telitacicept in Lupus Nephritis
32. The Relation Between Serum Zinc and Lupus Nephritis
33. Renal Survival in Patients with Lupus Nephritis
34. Zanubrutinib in Participants With Active Proliferative Lupus Nephritis
35. KYSA-3: A Study of Anti-CD19 Chimeric Antigen Receptor T-Cell (CD19 CAR T) Therapy, in Subjects With Refractory Lupus Nephritis
36. RESET-SLE: a Phase 1/2 Open-Label Study to Evaluate the Safety and Efficacy of CABA-201 in Subjects with Active Systemic Lupus Erythematosus
37. Lupus Landmark Study: A Prospective Registry and Biorepository
38. Anti-CD19 Chimeric Antigen Receptor T Cells for Refractory Systemic Lupus Erythematosus
39. Evaluating the Safety of Myfortic (Mycophenolate Sodium) in Patients With Lupus Nephritis
40. A Study to Evaluate the Safety and Preliminary Efficacy of ATA3219 in Participants with Systemic Lupus Erythematosus
41. Long-Term Voclosporin Treatment in Adolescent Subjects with Lupus Nephritis (VOCAL-EXT)
42. A Study of ANX009 in Adult Participants With Lupus Nephritis
43. Open-label Extension Study of Efficacy, Safety and Tolerability of Secukinumab in Patients With Active Lupus Nephritis
44. A Study to Evaluate the Safety and Efficacy of Obinutuzumab Compared With Placebo in Participants With Lupus Nephritis (LN)
45. Urinary G3BP as a Novel Biomarker in Lupus Nephritis
46. ACTHar in the Treatment of Lupus Nephritis (ACTHar)
47. An Open-label Study of Povetacicept (ALPN-303) in Autoimmune Kidney Diseases (RUBY-3)
48. KYSA-1: A Study of Anti-CD19 Chimeric Antigen Receptor T-Cell (CD19 CAR T) Therapy, in Subjects With Refractory Lupus Nephritis
49. AB-101 in Combination With B-Cell Depleting mAb in Patients Who Failed Treatment for Class III or IV Lupus Nephritis or Other Forms of Refractory Systemic Lupus Erythematosus
50. Phase II Study Assessing Safety and Efficacy of APL-2 in Glomerulopathies
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.